It is a nootropic drug invented in 1996 by a group Performing for Merck, Sharp and Dohme, that was the very first compound designed which acts as being a subtype-selective inverse agonist on the α5 subtype in the benzodiazepine binding web-site within the GABAA receptor. Sakae Naa (Combretum quadrangulare) is https://revivalschem.com/product/buy-1p-lsd-150-mcg-pellets/